Contact Us: Sales@finabio.com

Services

Fina BioSolutions offers bioconjugation services. We are noted for our expertise in conjugate vaccines and have extensive experience in the synthesis of conjugate vaccines, including proprietary methods.  Vaccines using chemistry developed by FinaBio’s founder, Andrew Lees, have  been administered to millions of children worldwide.

Fina BioSolutions protein services help biotech companies move from discovery to early clinical trials. We offer protein expression, purification and immunoassay design services.

Bioconjugation

Multi-angle Light Scattering (SEC-MALS)

Protein Services

Immunoassay Design & Antibodies


For questions regarding pricing, contact us at: Sales@finabio.com


News

  • About FinaBio
    Whitepaper
    Characterization of Fina Biosolutions’ Amino-Dextran
  • About FinaBio

Address

9430 Key West Ave., Suite 200
Rockville, MD 20850
877-346-2246 (877-FinaBio)
301-633-0464 (Andrew Lees, Scientific Director)
Finabio.net
ALees@FinaBio.com

About Us

Fina Biosolutions, LLC was founded in 2006 by Dr. Andrew Lees with an initial focus on helping emerging market vaccine manufacturers learn to make affordable conjugate vaccines. FinaBio has since grown to offer a variety of bioconjugation and protein services. The company is located in the heart of Maryland’s biotechnology corridor.